Opko Health Inc (OPK) Stock Price, Quote & News

Company Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 305 575 4100

Website: www.opko.com

Address:

4400 Biscayne Boulevard, Miami, United States

tymtested Dec. 24 at 8:14 PM

$OPK loss harvesting creates huge buying opportunity!

0 · Reply

Zerrat Dec. 24 at 6:27 PM

$OPK heading for year low for merry Christmas.

0 · Reply

tymtested Dec. 24 at 4:22 PM

$OPK at 7.3 OPKO has the highest equity rating it has been given in many months.. VERY BULLISH!

0 · Reply

Brasil07 Dec. 23 at 9:49 AM

$OPK this stock Is chained to Frost, until this link go on, we have no Hope

0 · Reply

tymtested Dec. 22 at 8:13 PM

$OPK dont know where that bit of green came from but bring it on!

1 · Reply

Mike18181 Dec. 22 at 12:17 PM

$OPK Sell ! Why? The team always loses, cant make the playoffs, projects a winning season , and the Results are In !!! 1 and 16 season again. ( But theres HOPE 🚩

1 · Reply

Sierradude Dec. 19 at 9:06 PM

$OPK Yet another coal in the stocking Christmas delivered by Frosty grinch.....I bet the execs will get millions though....

0 · Reply

Brasil07 Dec. 19 at 5:41 PM

$OPK I Hope that this Will be the last Christmas for Frosty

0 · Reply

carpenterinvestor Dec. 19 at 5:12 PM

$OPK just tax-loss harvested 15k shares. Still holding 5k because we will see $2!

0 · Reply

LongAllDay Dec. 19 at 4:39 PM

$OPK I hope frost has a boring Christmas cause his stock is boring and he makes me very sad cause I own OPK and sometimes I want to not

0 · Reply

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

Oct 29, 2025, 9:36 PM EDT - 2 months ago

OPKO Health, Inc. (OPK) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:05 PM EDT - 2 months ago

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

Oct 22, 2025, 4:05 PM EDT - 2 months ago

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Sep 15, 2025, 8:30 AM EDT - 3 months ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Jul 31, 2025, 9:19 PM EDT - 5 months ago

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:05 PM EDT - 5 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

Jun 30, 2025, 8:01 AM EDT - 6 months ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL

Jun 25, 2025, 11:00 AM EDT - 6 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

May 15, 2025, 8:00 AM EDT - 8 months ago

OPKO Health to Participate in Two Upcoming Investor Conferences

Apr 30, 2025, 7:52 PM EDT - 8 months ago

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

Apr 4, 2025, 8:00 AM EDT - 9 months ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Mar 17, 2025, 8:57 AM EDT - 10 months ago

OPKO and Entera partner to develop obesity pill

Mar 11, 2025, 7:00 AM EDT - 10 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Feb 27, 2025, 7:12 PM EST - 10 months ago

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:10 PM EST - 10 months ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Jan 9, 2025, 11:45 AM EST - 1 year ago

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 18, 2024, 8:00 AM EST - 1 year ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NXPL

Nov 14, 2024, 6:00 AM EST - 1 year ago

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

BABA NXPL

Nov 7, 2024, 8:30 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

Oct 7, 2024, 8:00 AM EDT - 1 year ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Oct 7, 2024, 8:00 AM EDT - 1 year ago

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

NXPL

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Aug 7, 2024, 4:06 PM EDT - 1 year ago

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Jul 17, 2024, 4:14 PM EDT - 1 year ago

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

May 31, 2024, 10:48 AM EDT - 1 year ago

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 7, 2024, 8:03 PM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 3, 2024, 8:00 AM EDT - 1 year ago

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 28, 2024, 8:00 AM EDT - 1 year ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Mar 5, 2024, 8:52 AM EST - 1 year ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Feb 27, 2024, 8:08 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 1 year ago

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 22, 2024, 4:05 PM EST - 1 year ago

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Jan 9, 2024, 4:05 PM EST - 2 years ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

Jan 4, 2024, 11:31 PM EST - 2 years ago

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 3, 2024, 5:05 PM EST - 2 years ago

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Nov 28, 2023, 7:00 AM EST - 2 years ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 7, 2023, 6:45 AM EST - 2 years ago

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPH

Nov 6, 2023, 7:32 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 4:05 PM EST - 2 years ago

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 2, 2023, 10:00 AM EDT - 2 years ago

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Oct 31, 2023, 8:00 AM EDT - 2 years ago

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 25, 2023, 4:25 PM EDT - 2 years ago

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 20, 2023, 1:30 PM EDT - 2 years ago

OPKO Health: FDA Approval To Save The Company

Sep 28, 2023, 4:08 PM EDT - 2 years ago

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Aug 4, 2023, 12:17 AM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

Jul 31, 2023, 2:19 PM EDT - 2 years ago

OPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings

Jul 25, 2023, 4:05 PM EDT - 2 years ago

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Jun 28, 2023, 6:45 AM EDT - 2 years ago

FDA Approves Pfizer's NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

PFE

tymtested Dec. 24 at 8:14 PM

$OPK loss harvesting creates huge buying opportunity!

0 · Reply

Zerrat Dec. 24 at 6:27 PM

$OPK heading for year low for merry Christmas.

0 · Reply

tymtested Dec. 24 at 4:22 PM

$OPK at 7.3 OPKO has the highest equity rating it has been given in many months.. VERY BULLISH!

0 · Reply

Brasil07 Dec. 23 at 9:49 AM

$OPK this stock Is chained to Frost, until this link go on, we have no Hope

0 · Reply

tymtested Dec. 22 at 8:13 PM

$OPK dont know where that bit of green came from but bring it on!

1 · Reply

Mike18181 Dec. 22 at 12:17 PM

$OPK Sell ! Why? The team always loses, cant make the playoffs, projects a winning season , and the Results are In !!! 1 and 16 season again. ( But theres HOPE 🚩

1 · Reply

Sierradude Dec. 19 at 9:06 PM

$OPK Yet another coal in the stocking Christmas delivered by Frosty grinch.....I bet the execs will get millions though....

0 · Reply

Brasil07 Dec. 19 at 5:41 PM

$OPK I Hope that this Will be the last Christmas for Frosty

0 · Reply

carpenterinvestor Dec. 19 at 5:12 PM

$OPK just tax-loss harvested 15k shares. Still holding 5k because we will see $2!

0 · Reply

LongAllDay Dec. 19 at 4:39 PM

$OPK I hope frost has a boring Christmas cause his stock is boring and he makes me very sad cause I own OPK and sometimes I want to not

0 · Reply

Love_To_Learn Dec. 18 at 12:33 PM

$SNGX need to move u aa bit out the way for the $AKAN $KITT situation due to indirect attachemnt ive palced to $OPK

0 · Reply

Mike18181 Dec. 16 at 11:22 PM

$OPK Opko presdent is a Mute !

0 · Reply

tymtested Dec. 16 at 10:28 PM

$OPK Im holding.

0 · Reply

This_Bull_Is_Retired Dec. 16 at 7:23 PM

$OPK To the DBAGS Mike, JAYGAY and Gassphager.

1 · Reply

This_Bull_Is_Retired Dec. 16 at 7:15 PM

$OPK Here you go Gassphager and Jay. Now let's see your.......bet $1000 you won't post it even though you said you would. You are mouth you two and Fred Goldberg AKA Mike

1 · Reply

Mike18181 Dec. 16 at 5:24 PM

$OPK Opko health, Inc. Symbol (OPK) is a Private company control by frost. Board member will also enjoy the fruit of the tree. As for public shareholders after 20 years tbere starting to come smell the coffee. The coffee is a Private brand, and only insider share a cup. ****ROE is irrelevant.. Shareholders, investment companies, public investors, analyst, Wallstreet realize its a dead company. They sold.. Put our clients into this, No Sir !

0 · Reply

Brasil07 Dec. 16 at 5:11 PM

$OPK this stock it's an hard prove Indeed, for my poor nerve

0 · Reply

Love_To_Learn Dec. 16 at 12:48 PM

$OPK very good off 1.33 1.35 res candles for later other pet

0 · Reply

Indyshaw Dec. 16 at 2:19 AM

$OPK nice to see the world’s largest asset manager- Blackrock - increase their position in OPK. Guaranteed they have some of the brightest analysts.

1 · Reply

Mike18181 Dec. 15 at 10:08 PM

$OPK 1.30 × 650m shs outstanding and frost has 348m shs make an already approved bid of 1.75 Take your own company private, and pulled the remainder off stock or Driftwood off the exchange. Theres nothing to watch and this unhealthy situation has people guessing what will come. All these positive developments produce Losses and frost is 90 and wont be coherent by Q2 2026. 1 billion to 1.3b exit

0 · Reply

Sierradude Dec. 12 at 5:42 PM

$OPK They announce year end bonuses yet?

2 · Reply

Biotechguy21 Dec. 12 at 1:43 PM

$OPK ceo in jail yet? 😂😂😂

0 · Reply

Market Cap	1.01B
Revenue (ttm)	713.14M
Net Income (ttm)	-53.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-7.46%
Debt to Equity Ratio	0.19

Volume	1,870,600
Avg Vol	2,741,132
Day's Range	N/A - N/A
Shares Out	767.70M
Stochastic %K	8%
Beta	1.34
Analysts	Strong Sell
Price Target	$2.57